BioInvent International AB's total assets for Q4 2024 were kr989.24M, a decrease of -9.03% from the previous quarter. SE:BINV total liabilities were kr103.42M for the fiscal quarter, a 22.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.